CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-17 | Kihara James Principal Accounting Officer | Option exercise | +1,982 | 13,028 | ||
| 2023-11-17 | Kihara James Principal Accounting Officer | Option exercise | +1,982 | 15,010 | ||
| 2023-11-17 | Kihara James Principal Accounting Officer | Option exercise · Restricted Stock Units | −1,982 | 7,931 | ||
| 2023-11-17 | Kihara James Principal Accounting Officer | Option exercise · Restricted Stock Units | −1,982 | 7,931 | ||
| 2023-10-12 | Ndu Adora Director | Option exercise | +4,381 | 4,381 | ||
| 2023-10-12 | Ndu Adora Director | Option exercise · Restricted Stock Units | −4,381 | 4,381 | ||
| 2023-10-06 | KIM AUSTIN D. EVP,General Counsel, Secretary | Sale | −16,369 | $21.96 | $359K | 45,857 |
| 2023-10-06 | DAVIS STEPHEN CEO | Sale | −51,563 | $21.96 | $1.1M | 89,131 |
| 2023-10-06 | DAVIS STEPHEN CEO | Option exercise · Restricted Stock Units | −103,999 | 173,332 | ||
| 2023-10-05 | KIM AUSTIN D. EVP,General Counsel, Secretary | Option exercise | +36,174 | 62,226 | ||
| 2023-10-05 | KIM AUSTIN D. EVP,General Counsel, Secretary | Option exercise · Restricted Stock Units | −36,174 | 60,289 | ||
| 2023-10-05 | DAVIS STEPHEN CEO | Option exercise | +103,999 | 140,694 | ||
| 2023-09-15 | Kihara James Principal Accounting Officer | Sale 10b5-1 | −2,000 | $25.88 | $52K | 10,778 |
| 2023-08-21 | Schneyer Mark C. EVP, Chief Financial Officer | Sale 10b5-1 | −10,000 | $29.00 | $290K | 15,682 |
| 2023-07-14 | DAVIS STEPHEN CEO | Option exercise 10b5-1 | +100,000 | $20.77 | $2.1M | 136,695 |
| 2023-07-14 | DAVIS STEPHEN CEO | Sale 10b5-1 | −100,000 | $30.04 | $3.0M | 36,695 |
| 2023-07-14 | DAVIS STEPHEN CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 220,000 | ||
| 2023-07-12 | DAVIS STEPHEN CEO | Sale 10b5-1 | −55,104 | $25.05 | $1.4M | 36,695 |
| 2023-07-11 | DAVIS STEPHEN CEO | Sale 10b5-1 | −16,498 | $25.00 | $412K | 91,799 |
| 2023-06-15 | Kihara James Principal Accounting Officer | Sale 10b5-1 | −2,000 | $24.15 | $48K | 9,144 |
Page 17 of 63 · 1,260 trades